Cargando…
Concomitant febuxostat enhances methotrexate-induced hepatotoxicity by inhibiting breast cancer resistance protein
Methotrexate (MTX) is an antifolate agent used for the treatment of various malignancies and is eliminated by breast cancer resistance protein (BCRP). Because febuxostat (FBX) is known to inhibit BCRP activity, FBX might exacerbate MTX-related adverse effects. In this study, we examined the drug-dru...
Autores principales: | Ikemura, Kenji, Hiramatsu, Shun-ichi, Shinogi, Yuri, Nakatani, Yusuke, Tawara, Isao, Iwamoto, Takuya, Katayama, Naoyuki, Okuda, Masahiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937279/ https://www.ncbi.nlm.nih.gov/pubmed/31889141 http://dx.doi.org/10.1038/s41598-019-56900-2 |
Ejemplares similares
-
Drug interactions of tacrolimus with letermovir and azole antifungals following hematopoietic stem cell transplantation: A retrospective observational analysis
por: Shinogi, Yuri, et al.
Publicado: (2023) -
Drug Repositioning of Proton Pump Inhibitors for Enhanced Efficacy and Safety of Cancer Chemotherapy
por: Ikemura, Kenji, et al.
Publicado: (2017) -
Risk factors for the development of hypermagnesemia in patients prescribed magnesium oxide: a retrospective cohort study
por: Wakai, Eri, et al.
Publicado: (2019) -
Opioid therapy duration before naldemedine treatment is a significant independent risk of diarrhea: a retrospective cohort study
por: Okamoto, Akiharu, et al.
Publicado: (2021) -
Impact of the number of repeated inhalations and patient characteristics on the residual amount of inhaled laninamivir octanoate hydrate dry powder in pediatric patients with influenza
por: Murasaka, Toshiki, et al.
Publicado: (2017)